Maravai Lifesciences Holdings Inc
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | +7.1% | +119.9% | +51.0% | +19.0% | -34.8% | -32.2% | -23.6% | |
| – | +12.5% | +447.6% | +123.2% | +14.6% | -17.5% | -38.7% | -31.0% | |
| – | +13.0% | +856.2% | +133.4% | +14.7% | -9.0% | -43.9% | -32.7% | |
| – | +13.0% | +856.2% | +133.4% | +14.7% | -9.0% | -43.9% | -32.7% | |
| – | +12.8% | +183.0% | +130.3% | +24.9% | -62.0% | -30.9% | -33.8% | |
| – | -0.7% | +134.5% | +54.8% | -16.3% | +19.1% | -2.6% | -19.1% | |
| – | +121.5% | +7.4% | -54.3% | +151.6% | – | – | – | |
| – | +0.0% | +0.0% | -31.9% | +85.7% | +14.9% | -51.0% | -19.0% | |
| – | -9.3% | -10.2% | -33.8% | +84.3% | +2.0% | -11.8% | -22.3% | |
| – | +10.6% | +157.6% | +23.0% | +0.3% | -49.3% | -38.2% | -7.7% | |
| – | -17.7% | +342.4% | -28.3% | +17.5% | -20.6% | -34.9% | -21.2% | |
| – | +0.0% | +140.0% | +62.0% | +20.4% | +9.8% | +6.7% | -60.3% | |
| – | +107.5% | -60.1% | +173.2% | -26.5% | +79.1% | +11.4% | -75.7% | |
| – | -0.2% | +57.9% | -0.8% | -0.5% | -0.6% | -44.0% | -1.4% | |
| – | -2.1% | -37.4% | +256.5% | +72.8% | -23.6% | -21.9% | -34.7% | |
| – | – | – | +21,511.4% | +119.3% | -29.4% | -50.7% | -92.8% | |
| – | +8.6% | +0.0% | +26.2% | +8.0% | +0.2% | +4.5% | +5.2% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.